Drug – bio-affecting and body treating compositions – Designated organic active ingredient containing – Heterocyclic carbon compounds containing a hetero ring...
Reexamination Certificate
2005-02-22
2005-02-22
Balasubramanian, Venkataraman (Department: 1624)
Drug, bio-affecting and body treating compositions
Designated organic active ingredient containing
Heterocyclic carbon compounds containing a hetero ring...
C514S231500, C514S272000, C514S275000, C544S317000, C544S320000, C544S321000, C544S326000, C544S328000, C544S330000, C544S331000, C544S111000
Reexamination Certificate
active
06858606
ABSTRACT:
This invention features pyrimidine compounds of formula (I):R1isin which one of Raand Rbis H or alkyl, and the other is aryl or heteroaryl optionally substituted with Rdand Rem; each of R2and R4is H; R3is H, alkyl, aryl, heteroaryl, cyclyl, heterocyclyl, or alkylcarbonyl; R5is H or alkyl; n is 0, 1, 2, 3, 4, 5, or 6; X is NRc; Y is covalent bond, CH2, C(O), C═N—Rc, C═N—ORc, C═N—SRc, O, S, S(O), S(O2), or NRc; Z is N or CH; one of U and V is N, and the other is CRc; and W is O, S, S(O), S(O2), NRc, or NC(O)Rc; in which Rcis H, alkyl, aryl, heteroaryl, cyclyl, heterocyclyl, or alkylcarbonyl; Rdis halogen, CN, alkyl alkyloxy, alkylcarbonyl, alkyloxycarbonyl, aryloxycarbonyl, heteroaryloxycarbonyl, hydroxyalkyl, alkylamino, or alkylaminocarbonyl; Reis halogen, CN, hydroxyl, alkyl, aryl, heteroaryl, alkoxyl, aryloxyl, or heteroaryloxyl; and m is 0, 1, 2, 3, or 4. The pyrimidine compounds can be used to treat an IL-12 overproduction-related disorder (e.g., rheumatoid arthritis, sepsis, Crohn's disease, multiple sclerosis, psoriasis, or insulin-dependent diabetes mellitus).
REFERENCES:
Trincheri , Current Opinion In Hematology 4: 59-66, 1997.*
Arvanitis, et al.Non-Peptide Corticotropin-Releasing Hormone Antagonists: Syntheses and Structure—Activity Relationships of 2-Anilinopyrimidines and -triazines. J. Med. Chem, vol. 42, 1999, pp. 805-818.
Mylari, et al.Sorbitol Dehydrogenase Inhibitors(SDIs):A New Potent, Enantiomeric SDI, 4-[2-1-R-Hydroxy-ethyl)-pyrimidin-4-yl]-piperazine-1-sulfonic Acid Dimethylamide. J. Med Chem, vol. 44, 2001, pp. 2695-2700.
Kostik Elena
Ono Mitsunori
Sun Lijun
Wada Yumiko
Balasubramanian Venkataraman
Edwards & Angell LLP
Hsi Jeffrey D.
Synta Pharmaceutical Corp.
LandOfFree
Pyrimidine compounds does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Pyrimidine compounds, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Pyrimidine compounds will most certainly appreciate the feedback.
Profile ID: LFUS-PAI-O-3506669